Quick Answer
Chemomab Therapeutics Ltd. reported Total Assets of $13.81 million for fiscal year 2025.
Chemomab Therapeutics Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $13.81M | -18.6% |
| 2024 | $16.96M | -23.4% |
| 2023 | $22.15M | -48.6% |
| 2022 | $43.06M | -33.1% |
| 2021 | $64.35M | +415.8% |
| 2020 | $12.48M | -36.8% |
| 2019 | $19.75M | +54.8% |
| 2018 | $12.76M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | $35.01M | -42.6% | -18.7% |
| December 31, 2022 | $43.06M | -33.1% | -14.2% |
| September 30, 2022 | $50.22M | -25.5% | -10.9% |
| June 30, 2022 | $56.38M | -20.1% | -7.5% |
| March 31, 2022 | $60.96M | +1.4% | -5.3% |
| December 31, 2021 | $64.35M | +415.8% | -4.6% |
| September 30, 2021 | $67.44M | +777.1% | -4.4% |
| June 30, 2021 | $70.52M | +604.1% | +17.3% |
- Chemomab Therapeutics Ltd. showed a decrease of -18.6% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Chemomab Therapeutics Ltd.’s total assets has grown by 8.2% (from $12.76 million to $13.81 million).
- The most recent figure is from Chemomab Therapeutics Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: